Skip to main content

Pharming today celebrates “hae day :-)” – the global awareness day for hereditary angioedema, a rare life-threatening condition.

Other updates

On 16 May each year, hereditary angioedema (HAE) patient organizations from around the world, led by the HAEi, the international umbrella organization for the world’s HAE patient groups, come together to support awareness of HAE; a rare, potentially life-threatening condition. hae day :-) aims to raise global awareness to ensure each and every patient receives faster diagnosis and the care they need to lead a better life.

Read more

Pharming Group announces publication of its Annual Report 2018 and a provisional commitment to invest in supplier

Financial updates

Pharming Group N.V. announces publication of its Annual Report for the financial year ended 31 December 2018. The Company also announces that it has made a provisional commitment to invest up to €1.6 million in cash and convert €2.5 million of prepayments into equity in its fill & finish partner BioConnection BV, which manufactures the final sealed vials of Pharming’s product RUCONEST® from the purified drug substance.

Read more

Pharming announces abstract presented at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting and sponsorship of the AAAAI Foundation Michael M. Frank, MD, FAAAI Lectureship

Conference attendance

Pharming Group N.V. announced today that an abstract was presented this week at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in San Francisco, CA. Additionally, Pharming is pleased to announce sponsorship of the AAAAI Foundation Michael M. Frank, MD, FAAAAI Lectureship.

Read more

Filters

  • Cookies: This website uses cookies Check the cookies page for more information Accept Decline